350 TREAT AVENUE, SAN FRANCISCO, CA
Announces Operating Results for Second Quarter 2025
Shareholder votes
Other Events
Earnings Release
News, Material Contracts
Changes in Board, Management or Compensation
Announces Departure of Chief Financial Officer and Reaffirms Q4 Revenue Guidance
Q2
Q1
FY 2024
Q3
FY 2023
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Certificate
SEC Form 25 - Delisting Notification
Registration of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Notification Filed by a National Security Exchange
Specialized Disclosure Report
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement